Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Race Oncology Ltd. ( (AU:RAC) ) just unveiled an update.
Race Oncology Ltd has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The announcement involves the issuance of 375 ordinary fully paid securities, reflecting the conversion of options or other convertible securities. This move is part of Race Oncology’s strategic efforts to enhance its capital structure and bolster its financial positioning in the oncology market.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the oncology sector, focusing on the development and commercialization of cancer therapeutics. The company is engaged in advancing innovative treatments to address unmet medical needs in cancer care.
YTD Price Performance: -3.33%
Average Trading Volume: 82,533
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$226.7M
See more data about RAC stock on TipRanks’ Stock Analysis page.
